犬や猫から分離された薬剤耐性菌「緑膿菌」の特徴を明らかに ~一部は人とペットで共有される可能性を示唆~

ad

2025-10-23 北海道大学

北海道大学の研究チームは、全国19都道府県・111施設で犬や猫から採取した緑膿菌197株を解析し、その約18%が医療上重要なカルバペネム系抗菌薬に耐性を示すことを発見した。さらに、人由来株と同一系統の菌株も確認され、動物と人の間で耐性菌が共有される可能性が示唆された。これらの結果は、伴侶動物を介した薬剤耐性菌の伝播リスクを理解する上で重要であり、「One Health(人と動物と環境の健康は一体)」の視点から継続的な監視が必要とされる。研究成果は『Journal of Antimicrobial Chemotherapy』誌に掲載。

犬や猫から分離された薬剤耐性菌「緑膿菌」の特徴を明らかに ~一部は人とペットで共有される可能性を示唆~
ペットから分離されるカルバペネム耐性緑膿菌とワンヘルスの重要性について

<関連情報>

伴侶動物由来カルバペネム非感受性緑膿菌のヒトへの潜在的健康リスク Potential human health risk of carbapenem-non-susceptible Pseudomonas aeruginosa from companion animals

Jirachaya Toyting-Hiraishi, Toyotaka Sato, Mana Tohyama, Taro Fujino, Kaho Okada, Kazuyoshi Sasaoka, Nozomu Yokoyama, Kana Torii, Akio Suzuki, Yuzo Tsuyuki … Show more
Journal of Antimicrobial Chemotherapy  Published:19 September 2025
DOI:https://doi.org/10.1093/jac/dkaf338

Abstract

Background and objectives

The close bond between companion animals and humans may accelerate the spread of antimicrobial-resistant bacteria. Pseudomonas aeruginosa, an opportunistic pathogen in both, poses a public health threat due to antimicrobial resistance (AMR) and diverse virulence factors. However, One Health-based comparison remains limited. This study investigated the current AMR status and molecular characteristics of P. aeruginosa in companion animals in Japan to assess potential human health risks.

Methods

We examined 197 P. aeruginosa clinical isolates from companion animals [dogs (n = 99) and cats (n = 98)] across Japan in 2024. Antimicrobial susceptibility to human clinical antibiotics was evaluated. In carbapenem-non-susceptible isolates, multilocus sequence typing and detection of resistance genes and virulence factors were performed.

Results

Ciprofloxacin (20.3%) and piperacillin (10.7%) showed the highest resistance rates, with 5.6% of isolates being multidrug-resistant. Carbapenem resistance rates were 6.1% for imipenem and 1.0% for meropenem. Thirty-five isolates (17.8%) exhibited carbapenem non-susceptibility but remained susceptible to cefepime, ciprofloxacin, or amikacin. Of 27 identified sequence types, 20 (77.1% of carbapenem-non-susceptible isolates) were known in humans, including two high-risk clones (ST233 and ST298; 8.6%) reported for the first time in Japanese companion animals. These isolates carried mutations in efflux pump-related genes and multiple virulence factors. One showed close genetic relatedness to a human isolate, suggesting possible interspecies transmission.

Conclusions

Our findings highlight the potential cross-species transmission risk of antimicrobial-resistant P. aeruginosa. Identification of shared high-risk clones with multiple virulence factors emphasizes the need for continuous vigilance and actions within the One Health framework.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました